Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice

Journal of Nutrition

Volumn 139, Issue 3, 2009, Pages 603-610

  Mañé, Josep ^a,b   Pedrosa, Elisabet ^a,b   Lorén, Violeta ^a,b   Ojanguren, Isabel ^a   Fluvià, Lourdes ^a,b   Cabré, Eduard ^a   Rogler, Gerhard ^c   Gassull, Miquel A ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b National Biomedical Research Institute of Liver and Gastrointestinal Diseases   (Spain)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COCONUT OIL; FATTY ACID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MEDIUM CHAIN TRIACYLGLYCEROL; MESSENGER RNA; SUNFLOWER OIL; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; OMEGA 6 FATTY ACID; TOLL LIKE RECEPTOR; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; COLITIS; COLON; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOWN REGULATION; EX VIVO STUDY; EXPLANT; FAT INTAKE; GERMFREE ANIMAL; HISTOLOGY; INCIDENCE; INTESTINE EXAMINATION; LAMINA PROPRIA; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; SCORING SYSTEM; SUPERNATANT; TISSUE HOMOGENATE; ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RANDOMIZATION; T LYMPHOCYTE SUBPOPULATION;

HELIANTHUS; MUS;

ANIMALS; APOPTOSIS; COLITIS; DIETARY FATS; FATTY ACIDS, OMEGA-6; GENE DELETION; GENE EXPRESSION REGULATION; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTE SUBSETS; TOLL-LIKE RECEPTORS; TRIGLYCERIDES;

EID: 62749174634     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.101170     Document Type: Conference Paper

References (65)

1. Fernández Bañares F, Cabré E, Esteve Comas M, Gassull MA. How effective is enterai nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enterai Nutr. 1995;19:356-64.
2. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enterai nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995;108:1056-67.
3. Messori A, Trallori G, D'Albasio G, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol. 1996;31:267-72.
4. Zachos M, Tondeur M, Griffiths AM. Enterai nutritional therapy for inducing remission in Crohn's disease. Cochrane Database Syst Rev. 2007;1:CD000542.
5. Fernández Bañares F, Cabré E, González-Huix F, Gassull MA. Enterai nutrition as primary therapy in Crohn's disease. Gut. 1994;35 Suppl l:S55-9.
6. Gorard DA. Enterai nutrition in Crohn's disease: fat in the formula. Eur J Gastroenterol Hepatol. 2003;15:115-8.
7. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologie analysis of Crohn's disease in Japan: increased dietary intake of n-6 polyunsatu-rated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan. Am J Clin Nutr. 1996;63:741-5.
8. Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shimoyama T, Inaba Y, Miyaké Y, Sasaki S, et al. Dietary risk factors for inflammatory bowel disease: a multicenter, case-control study in Japan. Inflamm Bowel Dis. 2005;11:154-63.
9. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996;334:1557-60.
10. Lorenz-Meyer H, Bauer P, Nicolay C, Schulz B, Purrmann J, Fleig WE, Scheurlen C, Koop I, Pudel V, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease: a randomized controlled multicenter trial. Scand J Gastroenterol. 1996;31:778-85.
11. González-Huix F, De León R, Fernández Bañares F, Esteve M, Cabré E, Acero D, Abad A, Figa M, Guilera M, et al. Polymeric enterai diet as primary treatment of active Crohn's disease: a prospective steroid-controlled trial. Gut. 1993;34:778-82.
12. Gassull MA, Fernández-Bañares F, Cabré E, Papo M, Giaffer MH, Sánchez-Lombraña JL, Richart C, Malchow H, González-Huix F, et al. Fat composition may be a clue to explain the primary therapeutic effect of enterai nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut. 2002;51:164-8.
13. Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr. 1982;36:950-62.
14. Wanten GJA, Naber AH. Cellular and physiological effects of medium-chain fatty acids. Mini Rev Med Chem. 2004;4:847-57.
15. Middleton SJ, Rucker JT, Kirby GA, Riordan AM, Hunter JO. Long-chain triglycerides reduce the efficacy of enterai feeds in patients with active Crohn's disease. Clin Nutr. 1995;14:229-36.
16. Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, Russo PM, Cucchiara S. Polymeric diet alone versus corticosteroids in the treatment of active pediatrie Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol. 2006;4:744-53.
17. Khoshoo V, Reifen R, Neuman MG, Griffiths A, Pencharz PB. Effect of low- and high-fat, peptide based diets on body composition and disease activity in adolescents with active Crohn's disease. JPEN J Parenter Enterai Nutr. 1996;20:401-5.
18. Sakurai T, Matsui T, Yao T, Takagi Y, Hirai F, Aoyagi K, Okada M. Short-term efficacy of enterai nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas. JPEN J Parenter Enterai Nutr. 2002;26:98-103.
19. Gassull MA, Mañé J, Pedrosa E, Cabré E. Macronutrients and bioactive molecules: is there a specific role in the management of inflammatory bowel disease? JPEN J Parenter Enterai Nutr. 2005;29 SupphS179-83.
20. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-74.
21. Sturm A, Fiocchi C. Life and death in the gut: more killing, less Crohn's. Gut. 2002;50:148-9.
22. Rakoff-Nahoum S, Hao L, Medzhitov R. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity. 2006;25:319-29.
23. Reeves PG, Ralston NV, Idso JP, Lukaski HC. Contrasting and cooperative effects of copper and iron deficiencies in male rats fed different concentrations of manganese and differntes source of sulfur amino acids in an AIN-93G-based diet. J Nutr. 2004;134:416-25.
24. Federation of European Laboratory Animal Science Associations. EUROGUIDE on the accommodation and care of animals used for experimental and other scientific purposes. London: Royal Society of Medicine Press Ltd.; 2007.
25. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin-10 gene-deficient mice. Gastroenterology. 1999; 116:1107-14.
26. Schwarz E, Saalmüller A, Gerner W, Claus R. Intraepithelial but not lamina propria lymphocytes in the porcine gut are affected by dexa-methasone treatment. Vet Immunol Immunopathol. 2005;105:125-39.
27. Lepage G, Roy CC. Direct transesterification of all classes of lipids in one-step reaction. J Lipid Res. 1986;27:114-20.
28. Dodds ED, McCoy MR, Rea LD, Kennish JM. Proton transfer chemical ionization mass spectrometry of fatty acid methyl esters separated by gas chromatography: quantitative aspects. Eur J Lipid Sci Technol. 2005;107:560-4.
29. Ohta N, Tsujikawa T, Nakamura T, Andoh A, Sasaki M, Bamba T. A comparison of the effects of medium- and long-chain triglycérides on neutrophil stimulation in experimental ileitis. J Gastroenterol. 2003;38: 127-33.
30. Caballero T, Nogueras F, Medina MT, Caracuel MD, de Sola C, Martínez-Salmerón FJ, Rodrigo M, García del Moral R. Intraepithelial and lamina propria leucocyte subsets in inflammatory bowel disease: an immunohistochemical study of colon and rectal biopsy specimens. J Clin Pathol. 1995;48:743-8.
31. Nüssler NC, Stange B, Hoffman RA, Schraut WH, Bauer AJ, Neuhaus P. Enhanced cytolytic activity of intestinal intraepithelial lymphocytes in patients with Crohn's disease. Langenbecks Arch Surg. 2000;385:218-24.
32. Davidson NJ, Leach MW, Fort MM, Thompson-Snipes LA, Kühn R, Müller W, Berg DJ, Rennick DM. T helper cell 1-type CD4 + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med. 1996; 184:241-51.
33. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-29.
34. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627-40.
35. Rennick DM, Fort MM. Lessons from genetically engineered animal models XII. IL-10-deficient (IL-10-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol. 2000;278:G829-33.
36. Berg DJ, Davidson NJ, Kühn R, Müller W, Menon S, Holland G, Thompson-Snipes LA, Leach MW, Rennick DM. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ TH1-like responses. J Clin Invest. 1996;98:1010-20.
37. Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick DM. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol. 1998;161:3143-9.
38. Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut. 2005;54:1182-93.
39. Beutler B. Innate immunity: an overview. Mol Immunol. 2004;40:845-59.
40. Akira S, Takeda K. Toll-like receptors signaling. Nat Rev Immunol. 2004;4:499-511.
41. Karrasch T, Kim JS, Muhlbauer M, Magness ST, Jobin C. Gnotobiotic IL-10(-/-); NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol. 2007;178:6522-32.
42. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol. 2006;8:1327-36.
43. 2 integrin expression, adhesion, and degranulation. JPEN J Parenter Enterai Nutr. 2000;24: 228-33.
44. Wanten GJA, Curfs JH, Meis JF, Naber AH. Phagocytosis and killing of Candida albicans by human neutrophils after exposure to structurally different lipid emulsions. JPEN J Parenter Enterai Nutr. 2001;25:9-13.
45. Kono H, Enomoto N, Connor HD, Wheeler MD, Bradford BU, Rivera CL, Kadiiska MB, Mason RP, Thurman RG. Medium-chain triglycerides inhibit free radical formation and TNF-α production in rats given enterai ethanol. Am J Physiol Gastrointest Liver Physiol. 2000;278: G467-76.
46. Nanji AA, Yang EK, Fogt F, Sadrzadeh SMH, Dannenberg AJ. Medium chain triglycérides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exp Ther. 1996;277: 1694-700.
47. Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaja S, Tahan SR, Dannenberg AJ. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology. 1997;26:1538-45.
48. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Dannenberg AJ. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J Pharmacol Exp Ther. 2001;299:638-44.
49. Nanji AA, Rahemtulla A, Daly T, Khwaja S, Miao LL, Zhao SP, Tahan SR. Cholesterol supplementation prevents necrosis and inflammation but enhances fibrosis in alcoholic liver disease in the rat. Hepatology. 1997;26:90-7.
50. Kono H, Fujii H, Asakawa M, Yamamoto M, Matsuda M, Maki A, Matsumoto Y. Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin. Ann Surg. 2003;237:246-55.
51. Sadeghi S, Wallace FA, Calder PC. Dietary lipids modify die cytokine response to bacterial lipopolysaccharide in mice. Immunology. 1999;96:404-10.
52. Tsujikawa T, Ohta N, Nakamura T, Satoh J, Uda K, Ihara T, Okamoto T, Araki Y, Andoh A, et al. Medium-chain triglycerides modulate ileitis induced by trinitrobenzene sulfonic acid. J Gastroenterol Hepatol. 1999; 14:1166-72.
53. Jorgensen JR, Clausen MR, Mortensen PB. Oxidation of short and medium chain C2-C8 fatty acids in Sprague-Dawley rat colonocytes. Gut. 1997;40:400-5.
54. Periago JL, Suárez MD. Effect of dietary olive oil, corn oil, and medium-chain triglycérides on the lipid composition of rat red blood cell membranes. J Nutr. 1990;120:986-94.
55. 13C]linoleic acid metabolism in preterm infants fed a formula with medium-chain triglycérides. J Lipid Res. 2003;44:41-8.
56. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983;220:568-75.
57. Moghaddami N, Costabile M, Grover PK, Jersmann HP, Huang ZH, Hii CS, Ferrante A. Unique effect of arachidonic acid on human neutrophil TNF receptor expression: up-regulation involving protein kinase C, extracellular signal-regulated kinase, and phospholipase A2. J Immunol. 2003; 171:2616-24.
58. Shaikh SR, Edidin M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am J Clin Nutr. 2006;84:1277-89.
59. Kapoor R, Huang YS. Gamma linolenic acid: an antiinflammatory omega-6 fatty acid. Curr Pharm Biotechnol. 2006;7:531-4.
60. Alzoghaibi MA, Walsh SW, Willey A, Fowler AA, Graham MF Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease. Clin Nutr. 2003;22:529-35.
61. Alzoghaibi MA, Walsh SW, Willey A, Yager DR, Fowler AA, Graham MR Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites. Am J Physiol Gastrointest Liver Physiol. 2004;286:G528-37.
62. O'Moráin C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Rd). 1984;288:1859-62.
63. Giaffer MH, North G, Holdsworth CD. Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease. Lancet. 1990;335:816-9.
64. Royall D, Jeejeebhoy KN, Baker JP, Allard JP, Habal FM, Cunnane SC, Greenberg GR. Comparison of amino acid v peptide based enterai diets in active Crohn's disease: clinical and nutritional outcome. Gut. 1994;35: 783-7.
65. Tsujikawa T, Ohta N, Nakamura T, Yasuoka T, Sato J, Fukunaga T, Itoh A, Uda K, Ihara T, et al. Medium-chain triglyceride-rich enterai nutrition is more effective than low-fat enterai nutrition in rat colitis, but is equal in enteritis. J Gastroenterol. 2001;36:673-80.